학술논문
Safety and efficacy of first-line treatment with doxorubicin, cyclophosphamide, bortezomib, dexamethasone and lenalidomide (ACVDL) in newly diagnosed multiple myeloma patients of all ages
Document Type
Abstract
Author
Source
In Clinical Lymphoma Myeloma and Leukemia September 2015 15 Supplement 3:e144-e144
Subject
Language
ISSN
2152-2650